Atul Kumar

About Atul Kumar

Motivational Startup, Quotes Writer. Chairman/ Head,Medicinal and Process Chemistry Division, Chief Scientist and Professor AcSIR. Chemical Sciences, CSIR-Central Drug Research Institute (CDRI), Lucknow-India. Ex-Dean and Course Coordinator, National Institute of Pharmaceutical Education and Research (NIPER, Raebareli) India, Chairman, CSIR-CDRI-Centre for Science outreach and Research (Under Corporate Social Responsibility)Dr. Atul Kumar is listed in Top 2 percentile scientist of world by Stanford University Major Research Achievements:Vigyan Ratna Star Award by Scifinder & Chemical Abstracts Services, USA Recipient of Organization of Pharmaceutical Producers of India (OPPI) OPPI SCIENTIST AWARD-2007 Incentive Award 2004,2005,2006,2007,2008,2009,2010, 2011, 2012, 2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023 ( Continuously : 19 year in row)Dr Atul Kumar has immense contributions in Women Health Research.Design and Discovery of New Anti-Osteoporosis Drug CandidateInvention of “CENTHANK”CDRI-99-373, An Anti-osteoporosis agent currently in Phase-I – Clinical Trails. Synthesis of Levo -Ormeloxifen, a drug for female Contraceptive First weekly contraceptive and DBU treatment agent In Clinical Trial.Design and Discovery of Novel Anti-Cancer Drug Candidate:Invention of CDRI-MND an anticancer agents showing promising anticancer activity compound is showing invitro anticancer activity better than Imatinib and Dasatinib C ompound is in Pre-clinical studies.Global Advisor council member of SciFinder -CAS Chemical Abstracts service ( CAS) A division of the American Chemical Society (ACS) Columbus, USAOne Pot Synthesis of Tryptanthrin in water ( An Anti-tubercular natural product), One Pot Green synthesis of a a β- artemether/arteethe ( An Antimalarial Drug)Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents has been the lead anticancer molecule Journal of Medicinal Chemistry10.1021/jm500873eFirst Synthetic compound to Target Cancer Stem Cell and opening an unexplored area in anticancer therapeutic. Develop Levo Ormeloxifene process An Anticancer agent Publication: Research papers: 107; Patents(Granted/ filed): 44.Research

Experience

1. Professor, Chairperson Ex Head, Medicinal & Process Chemistry Division, Chief Scientist, Cdri-csir

   Csir India

   Oct 1991 — Present

   Central Drug Research Institute is the Premier Institute for Drug Discovery and Biomedical Research, CDRI is internationally known in the area of Drug Discovery and Development.The Academy of Scientific & Innovative Research (AcSIR) is a world-class research academy in the area of Chemical, biological, physical, and engineering sciences of Council of Scientific & Industrial Research (CSIR).Inventor of New Antiosteoporosis drug candidate CENTHANK (CDRI-99/373) Currently in Phase I Clinical TrialInventor of new Anticancer agent CDRI-S00•••35 which is in Preclinical stage

Education

• University at Buffalo

  Visiting Scientist

  2002 — 2004

Skills

• High-Performance Liquid Chromatography (Hplc)
• Patents
• Professor/ Scientist
• Cancer Research
• Women Health Research
• Chromatography
• Cell Biology
• Green Chemistry
• Pharmaceutical Industry
• Biotechnology
• Stem Cell Research
• Pharmaceutics
• Drug Discovery
• Cell
• Clinical Research
• Anti Tb
• Medicinal Chemistry
• Hplc
• Biochemistry
• Osteoporosis
• Life Sciences
• Drug Design
• Drug Development
• Cancer